Profound Medical (PROF) Return on Capital Employed (2025 - 2026)
Profound Medical (PROF) posted quarterly Return on Capital Employed of 58.76% for Q1 2026, up 157.0% year-over-year from 22.86% in Q1 2025, and up 23.35% quarter-over-quarter from 76.66% in Q4 2025.
Profound Medical (PROF) Return on Capital Employed (2025 - 2026) Analysis & Trends
Profound Medical's Return on Capital Employed history runs 2 years deep, the most recent figure standing at 58.76% for Q1 2026.
- In Q1 2026, Return on Capital Employed rose 157.0% year-over-year to 58.76%; the TTM figure through Mar 2026 stood at 58.76% (up 157.0% YoY), while the FY2025 annual figure was 60.87%, up 457.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 58.76%, up from 76.66% in the prior quarter.
- The five-year high for Return on Capital Employed was 58.76% in Q1 2026, with the low at 117.15% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 12.08% |
| 10 | Profound Medical | 241.00 Mn | 202.73 Mn | 1.95 Mn | -60.14% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -60.14% |
| Mar 31, 2026 | -58.76% |
| Dec 31, 2025 | -76.66% |
| Sep 30, 2025 | -117.15% |
| Jun 30, 2025 | -85.41% |
| Mar 31, 2025 | -60.33% |